Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C

1203 SAFETY PROFILE OF DACLATASVIR IN COMBINATION WITH PEGINTERFERON alfa AND RIBAVIRIN IN 1100 PATIENTS WITH CHRONIC HCV INFECTION TREATED IN PHASE 2 STUDIES

(2013) I. Jacobson et al.   JOURNAL OF HEPATOLOGY

Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C

(2013) Edward J. Gane et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk for Immune-Mediated Graft Dysfunction in Liver Transplant Recipients With Recurrent HCV Infection Treated With Pegylated Interferon

(2012) Josh Levitsky et al.   GASTROENTEROLOGY

Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers

(2012) Ellen Hulskotte et al.   HEPATOLOGY

1120 PSI-7977 400 MG QD SAFETY AND TOLERABILITY IN THE FIRST 450 PATIENTS TREATED FOR 12 WEEKS

(2012) I. Jacobson et al.   JOURNAL OF HEPATOLOGY

1101 THE EFFECT OF RENAL IMPAIRMENT AND END STAGE RENAL DISEASE ON THE SINGLE-DOSE PHARMACOKINETICS OF PSI-7977

(2012) M.T. Cornpropst et al.   JOURNAL OF HEPATOLOGY

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial

(2012) Stanislas Pol et al.   LANCET INFECTIOUS DISEASES

Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation

(2012) Robert J. Fontana et al.   LIVER TRANSPLANTATION

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

(2012) Anna S. Lok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus

(2011) Varun Garg et al.   HEPATOLOGY

Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation

(2010) P. Guillouche et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients

(2010) Nazia Selzner et al.   JOURNAL OF HEPATOLOGY

Post-liver transplant cholestatic hepatitis C: A systematic review of clinical and pathological findings and application of consensus criteria

(2010) Tarun K. Narang et al.   LIVER TRANSPLANTATION

Impact of Pegylated Interferon and Ribavirin Treatment on Graft Survival in Liver Transplant Patients with Recurrent Hepatitis C Infection

(2008) B. J. Veldt et al.   AMERICAN JOURNAL OF TRANSPLANTATION